High prevalence of functional dyspepsia in nonalcoholic fatty liver disease
a cross-sectional study
Keywords:
Gastrointestinal diseases, Nonalcoholic fatty liver disease, Dyspepsia, Obesity, Diabetes mellitusAbstract
BACKGROUND: Gastrointestinal (GI) symptoms are frequent complaints from individuals with nonalcoholic fatty liver disease (NAFLD). Dyspepsia is a universal clinical symptom and is among the most common GI complaints observed in the general population, but its prevalence in the population with NAFLD has not been previously investigated. OBJECTIVE: To compare the prevalence of functional dyspepsia (FD) between patients with NAFLD and controls without liver disease. DESIGN AND SETTING: Cross-sectional study at the Outpatient Liver Clinic, University Hospital, Belo Horizonte, Brazil. METHODS: We included 96 NAFLD patients and 105 controls without liver disease. All participants were assessed for GI symptoms in accordance with the Rome III criteria. Evaluation methods included a questionnaire for FD (validated in Brazil), laboratory tests and upper GI endoscopy. RESULTS: Mean age and sex were similar between the groups. The NAFLD group presented higher frequency of proton-pump inhibitor usage (31.3% vs 4.8%; P < 0.001) and prevalence of FD (25.0% versus 12.4%; P = 0.021). The symptom frequencies were as follows: postprandial distress, 22.9% versus 11.4% (P = 0.030); postprandial fullness, 18.8% versus 10.5% (P = 0.095); early satiation, 8.3% versus 5.7% (P = 0.466); and epigastric pain or burning, 18.8% versus 5.7% (P = 0.004), in NAFLD patients and controls, respectively. Multivariate analysis demonstrated that female sex (odds ratio, OR 6.97; 95% confidence interval, CI: 1.51-32.12; P = 0.013) and NAFLD diagnosis (OR 2.45; 95% CI: 1.14-5.27; P = 0.021) were independently associated with FD occurrence. CONCLUSION: FD occurs more frequently in individuals with NAFLD than in controls without hepatic disease.
Downloads
References
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-57. PMID: 28714183; https://doi.org/10.1002/hep.29367.
Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease - Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. PMID: 26707365; https://doi.org/10.1002/hep.28431.
McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis. 2004;8(3):521-33, viii. PMID: 15331061; https://doi.org/10.1016/j.cld.2004.04.004.
Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21(1):17–26. https://doi.org/10.1055/s-2001-12926.
Clark JM, Diehl AM. Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology. 2003;124(1):248-50. PMID: 12512048; https://doi.org/10.1053/gast.2003.50032.
Singh SP, Kar SK, Panigrahi MK, et al. Profile of patients with incidentally detected nonalcoholic fatty liver disease (IDNAFLD) in coastal eastern India. Trop Gastroenterol. 2013;34(3):144-52. PMID: 24851523; https://doi.org/10.7869/tg.118.
Froutan Y, Alizadeh A, Mansour-Ghanaei F, et al. Gallstone disease founded by ultrasonography in functional dyspepsia: prevalence and associated factors. Int J Clin Exp Med. 2015;8(7):11283-8. PMID: 26379936.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377-90. PMID: 16678553; https://doi.org/10.1053/j.gastro.2006.03.008.
Suzuki H, Nishizawa T, Hibi T. Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. J Gastroenterol. 2006;41(6):513-23. PMID: 16868798; https://doi.org/10.1007/s00535-006-1847-5.
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005-23. PMID: 22488764; https://doi.org/10.1002/hep.25762.
Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. PMID: 19805654; https://doi.org/10.1161/CIRCULATIONAHA.109.192644.
Kahrilas PJ. Diagnosis of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98(3 Suppl):S15-23. PMID: 12644027; https://doi.org/10.1016/s0002-9270(03)00011-x.
Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353-67. PMID: 26187502; https://doi.org/10.1136/gutjnl-2015-309252.
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846-54. PMID: 17393509; https://doi.org/10.1002/hep.21496.
Rome Foundation. Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders. J Gastrointestin Liver Dis. 2006;15(3):307-12. PMID: 17203570.
Reisswitz PS, Mazzoleni LE, Sander GB, Francisconi CF. Portuguese validation of the Rome III diagnostic questionnaire for functional dyspepsia. Arq Gastroenterol. 2010;47(4):354-60. PMID: 21225145; https://doi.org/10.1590/s0004-28032010000400007.
Oshima T, Miwa H. Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil. 2015;21(3):320-9. PMID: 26095436; https://doi.org/10.5056/jnm14165.
Miele L, Cammarota G, Vero V, et al. Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis. 2012;44(12):1032-6. PMID: 22963909; https://doi.org/10.1016/j.dld.2012.08.005.
Catanzaro R, Calabrese F, Occhipinti S, et al. Nonalcoholic fatty liver disease increases risk for gastroesophageal reflux symptoms. Dig Dis Sci. 2014;59(8):1939-45. PMID: 24718860; https://doi.org/10.1007/s10620-014-3113-7.
Eusebi LH, Ratnakumaran R, Bazzoli F, et al. Prevalence of Dyspepsia in Individuals With Gastroesophageal Reflux-Type Symptoms in the Community: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018;16(1):39-48.e1. PMID: 28782675; https://doi.org/10.1016/j.cgh.2017.07.041.
Camilleri M. Advances in diabetic gastroparesis. Rev Gastroenterol Disord. 2002;2(2):47-56. PMID: 12122960.
Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999;44(6):1061-75. PMID: 10389675; https://doi.org/10.1023/a:1026647417465.
Quigley EM. The pathophysiology of diabetic gastroenteropathy: more vague than vagal. Gastroenterology. 1997;113(5):1790-4. PMID: 9352887; https://doi.org/10.1053/gast.1997.v113.agast971131790.
Maleki D, Locke GR 3rd, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160(18):2808-16. PMID: 11025791; https://doi.org/10.1001/archinte.160.18.2808.
Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol. 1993;28(5):427-32. PMID: 8511503; https://doi.org/10.3109/00365529309098244.
Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161(16):1989-96. PMID: 11525701; https://doi.org/10.1001/archinte.161.16.1989.
Wilm S, Helmert U. The prevalence of fullness, heartburn and nausea among persons with and without diabetes mellitus in Germany. Z Gastroenterol. 2006;44(5):373-7. PMID: 16688653; https://doi.org/10.1055/s-2006-926656.
Santareno S, Cerqueira J, Portugues J, et al. Papel do tecido adiposo e dos macrófagos no estado de inflamação crónica associada à obesidade: implicações clínicas [The role of adipose tissue and macrophages in chronic inflammation associated with obesity: clinical implications]. Acta Med Port. 2008;21(5):489-96. PMID: 19187692. Erratum in: Acta Med Port. 2020 Mar 2;33(3):217.
Ho W, Spiegel BM. The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither? Gastroenterol Hepatol (N Y). 2008;4(8):572-8. PMID: 21960939.
Nocon M, Labenz J, Jaspersen D, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study. J Gastroenterol Hepatol. 2007;22(11):1728-31. PMID: 17914941; https://doi.org/10.1111/j.1440-1746.2006.04549.x.
Le Pluart D, Sabaté J-M, Bouchoucha M, et al. Functional gastrointestinal disorders in 35,447 adults and their association with body mass index. Aliment Pharmacol Ther. 2015;41(8):758-67. PMID: 25728697; https://doi.org/10.1111/apt.13143.
de Oliveira SS, da Silva dos Santos I, da Silva JFP, Machado EC. Prevalência de dispepsia e fatores sociodemográficos [Prevalence of dyspepsia and associated sociodemographic factors]. Rev Saude Publica. 2006;40(3):420-7. PMID: 16810365; https://doi.org/10.1590/s0034-89102006000300009.
Jung JG, Yang JN, Lee CG, et al. Visceral adiposity is associated with an increased risk of functional dyspepsia. J Gastroenterol Hepatol. 2016;31(3):567-74. PMID: 26313910; https://doi.org/10.1111/jgh.13146.
Miwa H. Life style in persons with functional gastrointestinal disorders--large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil. 2012;24(5):464-71, e217. PMID: 22292849; https://doi.org/10.1111/j.1365-2982.2011.01872.x.
Lin L, Chang L. Benefits and Pitfalls of Change From Rome III to Rome IV Criteria for Irritable Bowel Syndrome and Fecal Incontinence. Clin Gastroenterol Hepatol. 2020;18(2):297-9. PMID: 31606457; https://doi.org/10.1016/j.cgh.2019.10.004.